This grant, offered by NIDA, National Institutes of Health, focuses on developing novel pharmacological strategies to treat pregnant/postpartum women with Substance Related Disorders (SRDs) and/or in utero substance-exposed neonates. It supports preclinical and clinical research aimed at identifying, evaluating, and developing safe and effective new pharmacotherapies, including novel chemical entities or immunotherapies. Furthermore, it encourages the evaluation of existing FDA-approved medications for their safety and efficacy in these specific populations. This initiative seeks to address a significant unmet medical need by advancing targeted and effective treatment options.
Opportunity ID: 45582
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-09-106 |
| Funding Opportunity Title: | Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 03, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2012 |
| Current Closing Date for Applications: | May 07, 2012 |
| Archive Date: | Jun 07, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments State governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Special district governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. The purpose of this FOA is to foster the development of novel pharmacological strategies for the treatment of pregnant/postpartum women with Substance Related Disorders (SRDs) and/or in utero substance exposed neonates. To that end, this FOA issued by NIDA, National Institutes of Health, will encourage applications to implement preclinical and clinical research directed towards: 1) the identification, evaluation, and development of safe and effective novel pharmacotherapies (e.g., new chemical entities or immunotherapies) for the treatment of pregnant/postpartum women with SRDs and/or in utero substance exposed neonates, and/or 2) the evaluation of the safety and efficacy of FDA approved medications (e.g., medications approved for a different indication) for the treatment of pregnant/postpartum women with SRDs and/or in utero substance exposed neonates. Mechanism of Support. This FOA will use the NIH Research Project Grant (R01) mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-107 that encourages applications under the Exploratory/Developmental (R21) grant mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-09-106.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.279 | ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00014837 | Dec 21, 2009 | Oct 15, 2010 | View |
| 93.279 | ADOBE-FORMS-A | Adobe-Forms-A | PKG00010749 | May 05, 2009 | Feb 20, 2010 | View |
| 93.279 | ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00021913 | Oct 15, 2010 | May 07, 2012 | View |
Package 1
Mandatory forms
45582 RR_SF424_1_2-1.2.pdf
45582 PerformanceSite_1_3-1.3.pdf
45582 RR_OtherProjectInfo_1_2-1.2.pdf
45582 RR_KeyPersonExpanded_1_2-1.2.pdf
45582 PHS398_CoverPageSupplement_1_4-1.4.pdf
45582 PHS398_ResearchPlan_1_3-1.3.pdf
45582 PHS398_Checklist_1_3-1.3.pdf
Optional forms
45582 PHS_CoverLetter_1_2-1.2.pdf
45582 PHS398_ModularBudget-1.1.pdf
45582 RR_Budget-1.1.pdf
45582 RR_SubawardBudget-1.2.pdf
Package 2
Mandatory forms
45582 RR_SF424-1.1.pdf
45582 RR_KeyPersonExpanded-1.1.pdf
45582 RR_OtherProjectInfo-1.1.pdf
45582 RR_PerformanceSite-1.1.pdf
45582 PHS398_CoverPageSupplement-1.1.pdf
45582 PHS398_ResearchPlan-1.1.pdf
45582 PHS398_Checklist-1.1.pdf
Optional forms
45582 PHS398_CoverLetter-1.1.pdf
45582 PHS398_ModularBudget-1.1.pdf
45582 RR_Budget-1.1.pdf
45582 RR_SubawardBudget-1.2.pdf
Package 3
Mandatory forms
45582 RR_SF424_1_2-1.2.pdf
45582 RR_OtherProjectInfo_1_3-1.3.pdf
45582 RR_KeyPersonExpanded_1_2-1.2.pdf
45582 PerformanceSite_1_4-1.4.pdf
45582 PHS398_ResearchPlan_1_3-1.3.pdf
45582 PHS398_CoverPageSupplement_1_4-1.4.pdf
45582 PHS398_Checklist_1_3-1.3.pdf
Optional forms
45582 RR_Budget-1.1.pdf
45582 RR_SubawardBudget-1.2.pdf
45582 PHS_CoverLetter_1_2-1.2.pdf
45582 PHS398_ModularBudget-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
